Business & Regulation

The EU takes the fight to the falsifiers with a new plan to implement packaging safety features.

Power List: Last year many nominated business leaders, but did we miss any important unsung heroes?

A personal experience led us to examine how adverse drug events data can be used to benefit the industry.

The serialization deadlines are coming. It may seem an age away, but preparing for serialization is not as straightforward as you may think. Do you really want to get left behind?

The final deadline for the European Union’s REACH regulation is approaching – and the home stretch will be the most challenging, especially for pharma companies that have failed to recognize their role.

From anti-cancer viruses to H3 blocking narcolepsy drugs – we present a year in European drug approvals

Are you worried about implementing new manufacturing technology in your plant? Never fear, the FDA’s Emerging Technology Team may be able to lend a helping hand

Oncology medication prices can vary significantly between countries – but by how much and why?

2015 has been a difficult year for Indian pharma companies – and ASSOCHAM is calling for the country to get its “house in order”.

The AMA calls for a ban on direct-to-consumer drug advertising in the US. But is such prohibition realistic?